| Application no. and date | 03737984.9 (espacenet) (Federated) (European Patent Register), 20030602 | | Patent/reg. no. and date | DK/EP 1513519, 20090218 | | Publication date | 20050316 | | Priority no. and date | US 385220 P, 20020603 | | EP pub. no. and date |
EP 1513519 20050316 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | 135696 | | Inventor | HUGHES, Thomas, Edward, 89 Wilson Road
Concord, MA01742, US,
HOLMES, David, Grenville, Holeeholzweg 54
CH-4102 Binningen, CH | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/40 (2006.01) , A61P 9/10 (2006.01) | | Title | Anvendelse af substituerede cyanopyrrolidiner til behandling af hyperlipidæmi | | Int. application no. | EP2003005762 | | Int. publication no. | WO2003101448 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
